The effect of locally applied platelet-rich fibrin on donor sites and recipient sites after split-thickness skin transplantatio

Vivolution A/S (Denmark)0 个研究点目标入组 20 人开始时间: 2006年2月17日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Patients undergoing surgery for chronic leg ulcer
•2. Aged over 18 years
•3. Written informed consent, the patient is expected to be able to complete the study
•4. Donor site area from 2 x (3 cm x 5 cm) to 2 x (7.6 cm x 15 cm)

•1. Non-Danish speaking
•2. Dementia
•3. Pregnant or breastfeeding women
•4. Patients treated with 10 mg of steroid or more daily
•5. Patients that have received thrombocyte-inhibiting medicine less than four days before surgery
•6. Patients not suited for general or spinal anaesthesia
•7. Patients whose donor site has been used as a donor site before
•8. Patients with skin diseases or pathological changes in the skin, including infection

发起方

Vivolution A/S (Denmark)